Shaoyi Chen
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Circular RNA-based therapeutic vaccine elicits potent antigen-specific antitumor immunity and remodels tumor microenvironment in lung cancer.
Journal: Cancer letters
Published: April 15, 2026
Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer.
Journal: Experimental hematology & oncology
Published: December 04, 2024
Evaluation of clinical and safety outcomes of cancer vaccines in patients with advanced non-small cell lung cancer after first-line therapy: a systematic review and meta-analysis.
Journal: EClinicalMedicine
Published: September 24, 2024
Synthetic circRNA therapeutics: innovations, strategies, and future horizons.
Journal: MedComm
Published: May 21, 2024
Restoring expression of tumour suppressor PTEN by engineered circular RNA-enhanced Osimertinib sensitivity in non-small cell lung cancer.
Journal: Clinical and translational medicine
Published: May 10, 2024
RNA technology and nanocarriers empowering in vivo chimeric antigen receptor therapy.
Journal: Immunology
Published: March 04, 2024
The current therapeutic cancer vaccines landscape in non-small cell lung cancer.
Journal: International journal of cancer
Published: November 30, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026